Skip to main content
. 2017 Aug 17;21:217. doi: 10.1186/s13054-017-1807-x

Table 3.

Plasma biomarker concentrations by acute kidney injury subphenotype

Biomarker No. of patients Biomarker concentration, median (IQR)
No AKI Resolving AKI Nonresolving AKI Resolving versus nonresolving (p value)
Endothelial dysfunction
 Ang-1, pg/ml 1212 6382 (3114, 10,409) 4393 (1957, 8856) 4033 (1638, 8048) 0.315
 Ang-2, pg/ml 1221 7985 (4636, 14,996) 14,924 (8367, 29,425) 15,126 (7047, 35,138) 0.287
 Ang-2/Ang-1 1212 1.3 (0.6, 3.5) 3.6 (1.1, 12.4) 3.6 (1.1, 18.1) 0.039
 sVCAM-1, ng/ml 1222 481 (382, 687) 530 (388, 783) 571 (446, 842) 0.023
Apoptosis and inflammation
 sTNFR-1, pg/ml 1161 5380 (3961, 8000) 10,063 (6147, 15,566) 9838 (5765, 18,358) 0.010
 sFas, pg/ml 1223 8810 (6880, 11,926) 11,586 (8095, 15,700) 12,879 (8938, 17,682) 0.001a
 IL-6, pg/ml 1149 75 (31, 178) 137 (59, 351) 147 (58, 375) 0.536
 IL-8, pg/ml 1160 11 (5, 20) 13 (7, 35) 14 (7, 33) 0.420

Abbreviations: AKI Acute kidney injury, Ang-1 Angiopoietin 1, Ang-2 Angiopoietin 2, IL Interleukin, sFas Soluble Fas, sTNFR-1 Soluble tumor necrosis factor receptor 1, sVCAM-1 Soluble vascular cell adhesion molecule 1

a p < 0.00625 based on Bonferroni correction for multiple hypotheses